Senti Biosciences

Senti Biosciences is a biotechnology company based in South San Francisco, California. The company currently employs 86 people and has generated $19 million in revenue. Senti Biosciences is dedicated to developing innovative cell and gene therapies. The company focuses on creating "gene circuits," which are unique combinations of DNA sequences designed to reprogram cells with biological logic. These gene circuits enable cells to sense their environment, make decisions, and respond accordingly, enhancing the effectiveness of cell and gene therapies. Senti Biosciences aims to leverage this technology to develop smarter medicines that can address a wide range of diseases. Senti Biosciences differentiates itself through its proprietary synthetic biology platform and its focus on developing gene circuits. This approach aims to improve the intelligence and therapeutic potential of cell and gene therapies, addressing diseases that are difficult to treat with conventional medicine. For more information about Senti Biosciences and its groundbreaking work, please visit their website at www.sentibio.com.